United Therapeutics Corp (NASDAQ: UTHR) stock enjoyed a major increase of 32.8% on 9/2/25. The shares closed at $404.81. Moreover, this advance was accompanied by exceptionally high trading volume at 505% of normal. The stock has risen 29.7% during the last week but has been weak relative to the market over the last nine months.
Current PriceTarget Research Rating
United Therapeutics has a current Value Trend Rating of C (Neutral). The Value Trend Rating reflects very contradictory signals from PTR’s two proprietary measures of a stock’s attractiveness. United Therapeutics has a good Appreciation Score of 81 but a very low Power Rating of 13, triggering the Neutral Value Trend Rating.
Rating Review
In light of this very positive price change we are reviewing our current Overall Rating of C. This review will be completed in the next several days.
Be the first to comment